Keywords: |
cancer chemotherapy; treatment outcome; review; multimodality cancer therapy; liver neoplasms; combined modality therapy; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; recurrent cancer; follow up; diagnostic accuracy; sensitivity and specificity; radiopharmaceuticals; metastasis; computer assisted tomography; neoplasm recurrence, local; carcinoembryonic antigen; recurrence; tomography, x-ray computed; pathology; molecular imaging; liver metastasis; blood; diagnostic agent; evaluation; tumor recurrence; liver tumor; echography; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; positron-emission tomography; pelvis tumor; prediction and forecasting; predictive value of tests; radiopharmaceutical agent; scintiscanning; recurrent disease; tracer; rectal neoplasms; rectum cancer; rectum tumor; theoretical study
|